William Frederick Brubaker, Jr

Title: William Frederick Brubaker, Jr: Innovator in Phosphodiesterase Inhibition

Introduction

William Frederick Brubaker, Jr. is a notable inventor based in Cheshire, CT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit phosphodiesterase 4 (PDE4). His innovative work has the potential to impact various therapeutic areas.

Latest Patents

Brubaker holds a patent for "Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs." This patent describes novel compounds that achieve PDE4 inhibition through unique chemical structures, specifically N-substituted aniline and diphenylamine analogs. The compounds of this invention are represented by Formula I, where R, R, R, and R are defined within the patent documentation. He has 1 patent to his name.

Career Highlights

Brubaker is associated with Memory Pharmaceuticals Corporation, where he has been instrumental in advancing research and development in the pharmaceutical sector. His work focuses on creating innovative solutions that address unmet medical needs.

Collaborations

Throughout his career, Brubaker has collaborated with esteemed colleagues, including Ashok Tehim and Allen T Hopper. These partnerships have fostered a collaborative environment that enhances the innovation process.

Conclusion

William Frederick Brubaker, Jr. is a distinguished inventor whose work in phosphodiesterase inhibition showcases his commitment to advancing pharmaceutical science. His contributions continue to pave the way for future innovations in the field.